Tata India Pharma & Healthcare Fund Direct Growth

Tata India Pharma & Healthcare Fund Direct Growth

+18.36%
3Y annualised
+0.64% 1D
NAV: 19 Nov '26
₹39.85
Min. for SIP
₹100
Fund size (AUM)
₹1,499.08 Cr
Expense ratio
1.09%
Rating
2

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
1 year₹60,000₹65,009
+8.35%
3 years₹1,80,000₹2,13,990
+18.88%
5 years₹3,00,000₹4,61,523
+53.84%
10 years₹6,00,000₹15,77,051
+162.84%

Holdings (42)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries LtdHealthcareEquity7.89%
Abbott India LtdHealthcareEquity5.66%
Divi's Laboratories LtdHealthcareEquity5.41%
Healthcare Global Enterprises LtdHealthcareEquity5.25%
Dr. Reddy's Laboratories LtdHealthcareEquity5.14%
Torrent Pharmaceuticals LtdHealthcareEquity4.73%
Apollo Hospitals Enterprise LtdHealthcareEquity4.55%
Max Healthcare Institute LtdHealthcareEquity4.28%
Rainbow Childrens Medicare LtdHealthcareEquity4.02%
Sai Life Sciences Ltd.HealthcareEquity3.22%
Syngene International LtdHealthcareEquity3.17%
Procter & Gamble Health LtdHealthcareEquity3.15%
Lupin LtdHealthcareEquity3.13%
Cipla LtdHealthcareEquity3.08%
Anthem Biosciences Ltd.HealthcareEquity2.99%
Natco Pharma LtdHealthcareEquity2.86%
FDC LtdHealthcareEquity2.69%
Bayer CropScience LtdMaterialsEquity2.68%
Pfizer LtdHealthcareEquity2.40%
Ami Organics LtdHealthcareEquity2.40%
Aster DM Healthcare LtdHealthcareEquity2.33%
Biocon LtdHealthcareEquity2.23%
Navin Fluorine International LtdMaterialsEquity2.15%
Sanofi Consumer Healthcare India LtdHealthcareEquity1.99%
Ajanta Pharma LtdHealthcareEquity1.59%
Alkem Laboratories LtdHealthcareEquity1.40%
Dr. Agarwal’S Health Care Ltd.HealthcareEquity1.31%
Gillette India LtdConsumer StaplesEquity1.25%
Nestle India LtdConsumer StaplesEquity1.09%
Sumitomo Chemical India LtdMaterialsEquity1.01%
Prasol Chemicals Ltd.MaterialsEquity0.85%
Glaxosmithkline Pharmaceuticals LtdHealthcareEquity0.69%
Zim Laboratories LtdHealthcareEquity0.57%
Manipal Health Enterprises LtdHealthcareEquity0.57%
Molbio Diagnostics Ltd.HealthcareEquity0.53%
Gujarat Fluorochemicals LtdMaterialsEquity0.51%
Symbiotec Pharmalab Ltd.HealthcareEquity0.48%
PI Industries LtdMaterialsEquity0.46%
RepoUnspecifiedRepo0.19%
Cash/Net Current AssetsUnspecifiedCash/Net Current Assets0.07%
Dr. Lal Pathlabs LtdHealthcareEquity0.03%
Ipca Laboratories LtdHealthcareEquity0.00%

Minimum investments

Min. for 1st investment
₹5,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹100

Returns and rankings

Name3Y5Y10YAll
Fund returns+18.4%+15.8%+15.8%+13.5%
Category average (Equity Sectoral)+23.0%+17.3%+16.2%+17.6%
Rank (Equity Sectoral)1164--

Exit load, stamp duty and tax

Exit load

Exit load of 0.25% if redeemed within 30 days.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.

Fund management

Education
Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Experience
Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services

About Tata India Pharma & Healthcare Fund Direct Growth

Tata India Pharma & Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Tata Mutual Fund. This scheme was made available to investors on 30 Jun 1995. Rajat Srivastava is the Current Fund Manager of Tata India Pharma & Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹2,28,484 Cr and the Latest NAV as of 19 Nov 2026 is ₹39.85. The Tata India Pharma & Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹5,000. Exit load of 0.25% if redeemed within 30 days. ;

Investment Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)#14 in India
Total AUM₹2,28,484.27 Cr
Date of Incorporation30 Jun 1995
Launch Date30 Jun 1995
Address9th Floor, Mafatlal Centre,Nariman Point, Mumbai 400021
CustodianStandard Chartered Bank
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,